GLI1 and gastric cancer: It was worthy of note that most studies did not distinguish between patients who underwent radical resection and those receiving palliative surgery, which have significant differences in clinicopathological features and prognosis, when assessing the association of CD44, Shh, and Gli1 protein levels in GC.